Malta Centre

Phase OnePhase TwoPhase Three View Centre Details
Centre:Malta, Malta ( Eastern Mediterranean )
Principal Investigator:Professor Stephen Montefort
Age Groups:13-14, 6-7Timeframe:13-14yr:February 1995 to October 1995
6-7yr:May 1994 to June 1994
Sampling Frame:13-14yr: All state and private schools in Malta and island of Gozo.
6-7yr:All state schools in Malta and island of Gozo.
Phase OneView Centre DetailsPhase TwoPhase Three
Centre:Malta, Malta ( Eastern Mediterranean )
Principal Investigator:Professor Stephen Montefort
Age Groups:13-14, 6-7Timeframe:October 2001 to June 2002
Sampling Frame:All schools in Malta and Gozo.

Personnel

Professor Stephen Montefort

Professor Stephen Montefort

Department of Medicine
University of Malta
Appt 121 Tas- Sellum Residence

Malta

Roles:

  • ISAAC Steering Committee
  • Regional Coordinator for Eastern Mediterranean
  • National Coordinator for Malta
  • Phase One Principal Investigator for Malta
  • Phase Three Principal Investigator for Malta

ISAAC in Malta

This study was a first for our small country where we managed to gather a strong set of data which we could reliably compare to other countries. This was especially significant as the numbers required by ISAAC to be recruited were a good percentage of Maltese children in the chosen age-groups. The results have opened the eyes of the health authorities and the public to the very real problem our country has with childhood allergic conditions. We have managed to publish our findings and this was an added bonus to our medical department. So all in all our experience in ISAAC has certainly been very good. This should encourage us to partake in future similar international studies.

Findings

Malta seemed to have amongst the highest prevalences of allergic condition in the Mediterranean with the rate of rhinoconjunctivitis in 13 – 14 year olds being third highest in the world in phase 1 of the study. In the younger age group we have noticed that along the years between phase 1 and phase 3 we had a very significant increase in the prevalence of wheezing and rhinitis but not eczema. Thankfully this was also associated with better control and decresase in severity of the conditions studied. In the older age groups the prevalences tended to plateau and in the case of rhinitis and eczema, they actually decreased significantly.